Simplified antibiotic guidelines in urology are associated with decreased multidrug-resistant Enterobacterales

被引:1
|
作者
Roger, Pierre-Marie [1 ,2 ]
Bastian, Sylvaine [3 ]
Breurec, Sebastien [2 ,3 ,4 ,5 ]
Saliege, Marion [6 ]
Blanchet, Pascal [2 ,7 ,8 ]
Brureau, Laurent [2 ,7 ,8 ]
机构
[1] Ctr Hosp Univ Guadeloupe, Infectiol, Guadeloupe, France
[2] Univ Antilles, Fac Med, Guadeloupe, France
[3] Ctr Hosp Univ Guadeloupe, Serv Microbiol, Guadeloupe, France
[4] Inst Pasteur Guadeloupe, Lab Interact Ecosyst Microbiens, Guadeloupe, France
[5] INSERM, Ctr Invest Clin 1424, Paris, France
[6] Ctr Hosp Univ Guadeloupe, Pharm, Guadeloupe, France
[7] Ctr Hosp Univ Guadeloupe, Urol, Guadeloupe, France
[8] Univ Rennes, Inst Rech St Environm & Travail, INSERM, EHESP,UMR S 1085, F-97110 Pointe A Pitre, France
来源
INFECTIOUS DISEASES NOW | 2023年 / 53卷 / 07期
关键词
Urology; Antimicrobial stewardship; Antibiotics; Bacteremia; Multidrug-resistance Enterobacterales; URINARY-TRACT-INFECTIONS; RISK-FACTORS; ESCHERICHIA-COLI; EPIDEMIOLOGY; STEWARDSHIP;
D O I
10.1016/j.idnow.2023.104763
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose: A simplified therapeutic guideline (STG) was established in our urology ward in 2019 for urinary infections. Our aim was to describe the level of physician adherence to STG and the impact of a limited number of antibiotic compounds on the rate of multidrug-resistant (MDR) bacteria. As guidelines should improve patient care, unfavorable outcomes were also reported.Methods: The STG for community-acquired and nosocomial urinary infections, including six antibiotics, was established in November 2019 and has been officially applied since January 2020. Treatment duration has to be <= 14 days. We conducted a before-after study to measure physician adherence to the STG for bacteremia treatment between January 2017 and December 2022. Adherence was defined as exclusive use of STG antibiotics. All isolated bacteria from blood cultures were recorded, including MDR Enterobacterales, defined as AmpC b-lactamase- or ESBL-producing strains. Unfavorable outcomes were defined as uncontrolled infection, a second surgical procedure, ICU requirement, and/or death.Results: Seventy-six cases of bacteremia occurred between January 2017 and December 2019, and ninety between January 2020 and December 2022. The main comorbid condition was urological cancer (46%). The main reason for surgery was ureteral stent (32%). Antibiotic management in accordance with STG increased from 18% to 52%, p < 0.001, and treatments > 14 days decreased from 53% to 28%, p < 0.001. MDR Enterobacterales bacteremia was reduced from 52% to 35%, p = 0.027. The rate of unfavorable outcomes was unchanged. Conclusion: STG adherence in urology was satisfactory and associated with reduced MDR Enterobacterales bacteremia.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Multidrug-resistant Salmonella associated with AmpC hyperproduction
    Horton, JM
    Sing, RF
    Jenkins, SG
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) : 1348 - 1348
  • [32] Treatment Outcomes Associated with Multidrug-resistant Tuberculosis
    Gupta, Nitin
    Jorwal, Pankaj
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2018, 10 (03) : 125 - 128
  • [33] Status of and comprehensive preventive strategies for multidrug-resistant organisms in Korea: a focus on carbapenem-resistant Enterobacterales
    Park, Do Hyeon
    Choe, Pyoeng Gyun
    EWHA MEDICAL JOURNAL, 2024, 47 (03):
  • [34] The antibiotic resistance and pathogenicity of a multidrug-resistant Elizabethkingia anophelis isolate
    Wang, Mingxi
    Gao, Hongzhi
    Lin, Nanfei
    Zhang, Yaping
    Huang, Nan
    Walker, Edward D.
    Ming, Desong
    Chen, Shicheng
    Hu, Shaohua
    MICROBIOLOGYOPEN, 2019, 8 (11):
  • [35] Zidovudine in synergistic combination with fosfomycin: an in vitro and in vivo evaluation against multidrug-resistant Enterobacterales
    Antonello, Roberta Maria
    Di Bella, Stefano
    Betts, Jonathan
    La Ragione, Roberto
    Bressan, Raffaela
    Principe, Luigi
    Morabito, Stefano
    Gigliucci, Federica
    Tozzoli, Rosangela
    Busetti, Marina
    Knezevich, Anna
    Furlanis, Linda
    Fontana, Francesco
    Luzzaro, Francesco
    Luzzati, Roberto
    Lagatolla, Cristina
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 (01)
  • [36] Management of multidrug-resistant tuberculosis: main recommendations of the Brazilian guidelines
    de Almeida Ballestero, Jaqueline Garcia
    Garcia, Juliana Masini
    Bollela, Valdes Roberto
    Ruffino-Netto, Antonio
    Pretti Dalcolmo, Margareth Maria
    Scarpel Moncaio, Ana Carolina
    Miguel, Nicoly Sanches
    Rigolin, Isabela Zaccaro
    Palha, Pedro Fredemir
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2020, 46 (02) : 1 - 9
  • [37] A novel everninomicin antibiotic active against multidrug-resistant bacteria
    Chu, M
    Mierzwa, R
    Patel, M
    Jenkins, J
    Das, P
    Pramanik, B
    Chan, TM
    TETRAHEDRON LETTERS, 2000, 41 (35) : 6689 - 6693